HOME >> BIOLOGY >> NEWS
Gladstone building honored with San Francisco Business Times award

The new J. David Gladstone Institutes research facility, located at Mission Bay in San Francisco and dedicated in December, is the recipient of the San Francisco Business Times 2004 Real Estate Deal of the Year Award as Best New Office R&D Development/San Francisco. The honor is announced in a special section of the Business Times current (March 25-31) issue.

"We are delighted to receive this recognition," says Gladstone's Vice President of Administrative Affairs, Dan Oshiro, who accepted the award on behalf of the institutes at a banquet at the Palace Hotel in San Francisco, on March 23. "When our three trustees decided back in 1999 to purchase and develop land adjacent to the new UCSF Mission Bay campus, it was, frankly, a bit of a gamble, tempered by their astute real estate acumen. The result, a stunning new facility, offers many advantages, placing Gladstone at the center of an emerging biotech corridor in a region that is at the forefront of medical research."

In his acceptance comments, Oshiro lauded the efforts and teamwork of project manager Todd Sklar of Mezzatesta Sklar, prime contractor Rudolph and Sletten and architects NBBJ San Francisco, all of whom worked hand in hand with Gladstone's operations department and end users throughout the design and construction phases. He further acknowledged the City and County of San Francisco, particularly the San Francisco Redevelopment Agency, whose cooperation was critical to completion of the project ahead of schedule.

To be eligible for the Business Times award, new projects must have broken ground or been completed in calendar year 2004 and must be located in San Francisco, San Mateo, Alameda, Contra Costa or Marin counties or the city of Palo Alto. Six industry judges joined the Business Times editorial staff to consider not only the size and value of projects, but also their community impact, transit impact, financial backing, quality of design and suitability of land use.

For
'"/>

Contact: John Watson
jwatson@gladstone.ucsf.edu
415-734-2019
University of California - San Francisco
31-Mar-2005


Page: 1 2

Related biology news :

1. Gladstones Deepak Srivastava receives E. Mead Johnson Award for achievement in pediatrics
2. Gladstone scientists identify critical gene factor in heart development
3. Gladstone scientists prove neurons produce Alzheimers-linked apolipoprotein E
4. Gladstone Institutes receives funding for training grant from stem cell institute
5. Gladstone researchers hone in on differentiation of heart stem cells
6. Gladstone study links Alzheimers with toxic protein fragments
7. Gladstone researchers identify new drug target for Alzheimers disease
8. Gladstone Institutes assists with Exploratorium stem cell exhibit
9. CIRM awards $2.4 million training grant to the Gladstone Institutes
10. Gladstone investigators discover how resting T cells avoid HIV infection
11. Gladstone investigator Steve Finkbeiner wins prestigious Lieberman Award

Post Your Comments:
(Date:6/17/2013)... State University research associate has received a prestigious fellowship ... prevent the spread of malaria. , Bart Bryant, research ... Health,s National Research Service Award Individual Postdoctoral Fellowship, which ... Kansas State University researcher to receive the award and ... such an award. , Bryant, a university doctoral graduate ...
(Date:6/17/2013)... French . A ... Alzheimer,s disease can be reversed with treatment. The study by ... Neuro, at McGill University and at Universit de Montral found ... brain of mice with advanced Alzheimer,s disease (AD) recovers memory ... of Neuroinflammation in May, also suggest an underlying mechanism ...
(Date:6/15/2013)... -- A drug approved in Europe to treat osteoporosis ... breast cancer cells, even in cancers that have become ... Cancer Institute study. , The findings, presented June 15, ... Francisco, indicate that the drug bazedoxifene packs a powerful ... breast cancer cell growth, but also flags the estrogen ...
Breaking Biology News(10 mins):NIH fellowship helps researcher fight malaria, understand mosquito immunity 2Blocking overactive receptor in Alzheimer's recovers memory loss and more 2Osteoporosis drug stops growth of breast cancer cells, even in resistant tumors 2
(Date:6/18/2013)... June 18, 2013 Mapi Pharma Ltd. ... and innovative intermediates, and finished dosage forms based on selected ... granted a United States patent for ... Europe for the oral treatment of moderate-to-severe acute ... Intermediate Compounds and Processes for the Preparation of Tapentadol ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 This ... of pharmaceutical advertising and promotion, and review the ... will learn how to apply these principles through ... ,     The fundamentals on FDA regulations ... promotional labeling ,     Assessing traditional and newer ...
(Date:6/18/2013)... , June 18, 2013 ... has announced the addition of the ... Microspheres, & Nanoparticles], Devices [Disposables & Reusable, ... Auto Injectors] & Therapeutics [Diabetes & Oncology] ... to their offering.      (Logo: ...
(Date:6/18/2013)... June 18, 2013 As a ... Inc proudly announces the release of their infographic ... Fitness ". , MeMD's goal was to leverage ... of Health 2.0, Health 3.0 and mHealth.The infographic ... transform medical care and the fitness industry in ...
Breaking Biology Technology:Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2Drug Advertising and Promotion Labeling: FDA Regulations, New Webinar Hosted by Xtalks 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 3MeMD, Inc Releases Infographic Featuring the Top Eight Technologies that are Revolutionizing Health and Fitness Today 2
Cached News: